Cat. No. | Product name | CAS No. |
DC22010 |
B591
B591 (B-591) is a potent, specific pan-PI3K inhibitor with IC50 of 1.3/0.36/1.1/1.58 uM for PI3Kα/β/γ/δ, respectively. |
1498412-41-1 |
DC22011 |
BAA473
BAA473 (BAA-473) is a bile acid analogue that functions as the first small molecule activator of the Pyrin inflammasome, induces secretion of IL18 in LPS-primed PBMCs. |
20231-68-9 |
DC10859 |
Baccatin III
Featured
Baccatin III is the precursor to paclitaxel/ taxol. Antileukaemic and antitumor agent isolated from the bark of the Pacific yew tree (Taxus breviofolia). |
27548-93-2 |
DC20063 |
BACE1-IN-2
BACE1-IN-2 is a 1,4-Oxazine β-Secretase 1 (BACE1) inhibitor with an IC50 of 22 nM. |
1352416-78-4 |
DCAPI1066 |
Bacitracin zinc
Bacitracin zinc |
1405-89-6 |
DC8858 |
Bafilomycin A1(Baf-A1)
Featured
Bafilomycin A1 is a vacuolar H+-ATPase inhibitor with IC50 of 0.44 nM. |
88899-55-2 |
DC20740 |
BAL30072
BAL30072 is a monocyclic beta-lactam antibiotic that shows potent activity against MDR Pseudomonas aeruginosa and Acinetobacter sp. Isolates with MIC90 of 8 and 4 ug/ml. |
941285-15-0 |
DCAPI1046 |
Balofloxacin
Balofloxacin |
127294-70-6 |
DC9562 |
Balsalazide
Balsalazide is an anti-inflammatory compound used in the treatment of Inflammatory Bowel Disease. |
80573-04-2 |
DC10502 |
BAPTA/AM(BAPTA-AM)
Featured
BAPTA/AM is a membrane permeable form of BAPTA, a selective chelator of Ca2+. |
126150-97-8 |
DC10564 |
BAR 502
Featured
BAR502 is a dual FXR and GPBAR1 agonist with IC50 values of 2 μM and 0.4 μM, respectively. |
1612191-86-2 |
DC20317 |
Barbadin
Barbadin is a small molecule that selectively inhibits the β-arrestin/β2-adaptin interaction (IC50=19.1/15.6 uM for β-arrestin1/2) without effect on the formation of receptor/β-arrestin complexes. |
356568-70-2 |
DC12663 |
Bax channel blocker(BAI-1)
Featured
Bax channel blocker is a potent inhibitor of Bax-mediated mitochondrial cytochrome C release (IC50 = 0.52 μM). Suggested to inhibit Bax channel formation/activity. |
335165-68-9 |
DC23719 |
BAY 1024767
BAY 1024767 (BAY1024767) is a higly potent antagonist of androgen receptor (AR) wild-type (IC50=46 nM) and mutant forms located in the AR ligand-binding domain (LBD). |
1273068-71-5 |
DC20750 |
BAY 1143269
BAY 1143269 is a potent, selective, orally bioavailable inhibitor of MNK1 with enzyme IC50 of 40 nM at 2 mM ATP. |
|
DC23386 |
BAY 1238097
BAY 1238097 is a novel BET bromodomain inhibitor with IC50 of 50 nM, inhibits the interaction between BRD4, BRD3 or BRD2 and H4 with IC50 values of 63 nM, 609 nM and 2430 nM in the NanoBRET assay. |
1564268-08-1 |
DC20589 |
BAY 1251152
Featured
BAY 1251152 (VIP152 ) is the first potent, selective, orally available PTEFb/CDK9 inhibitor with biochemical IC50 of 9 nM and MOLM13 cell IC50 of 29 nM, displays> 50-fold selectivity against other CDKs. |
1610358-56-9 |
DC23745 |
BAY-2402234
Featured
BAY 2402234 (BAY2402234) is a novel potent, selective, orally bioavailable DHODH inhibitor with IC50 of 1.2 nM (human full-length DHODH). |
2225819-06-5 |
DC10291 |
Bay 41-4109 less active enantiomer
Bay 41-4109 less active enantiomer shows less activity than Bay 41-4109. BAY 41-4109 is a potent inhibitor of human hepatitis B virus (HBV) with an IC50 of 53 nM. |
476617-51-3 |
DC20747 |
BAY 41-8543
BAY 41-8543 is an NO-independent sGC (soluble guanylyl cyclase) stimulator, inhibits collagen-mediated aggregation in washed human platelets (IC50=90 nM). |
256498-66-5 |
DC7323 |
Pritelivir(BAY-57-1293)
Featured
BAY 57-1293 represents a new class of potent inhibitors of herpes simplex virus (HSV) that target the virus helicase primase complex. |
348086-71-5 |
DC4113 |
Cinaciguat (BAY 58-2667)
Featured
BAY 58-2667 is a nitric oxide (NO)- and heme-independent soluble guanylyl cyclase activator. Displays potent cardiovascular effects. |
329773-35-5 |